These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9510897)

  • 1. Cross-reactivity of fosphenytoin in four phenytoin immunoassays.
    Datta P; Dasgupta A
    Clin Chem; 1998 Mar; 44(3):696-7. PubMed ID: 9510897
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays.
    Kugler AR; Annesley TM; Nordblom GD; Koup JR; Olson SC
    Clin Chem; 1998 Jul; 44(7):1474-80. PubMed ID: 9665426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer.
    Frank EL; Schwarz EL; Juenke J; Annesley TM; Roberts WL
    Am J Clin Pathol; 2002 Jul; 118(1):124-31. PubMed ID: 12109846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin.
    Roberts WL; De BK; Coleman JP; Annesley TM
    Clin Chem; 1999 Jun; 45(6 Pt 1):829-37. PubMed ID: 10351992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosphenytoin in infants.
    Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
    J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of alkaline phosphatase to correct the underestimation of fosphenytoin concentration in serum measured by phenytoin immunoassays.
    Dasgupta A; Warner BF; Datta P
    Am J Clin Pathol; 1999 Apr; 111(4):557-62. PubMed ID: 10191778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug, fosphenytoin in human plasma and ultrafiltrate.
    Cwik MJ; Liang M; Deyo K; Andrews C; Fischer J
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):407-14. PubMed ID: 9210446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
    Dasgupta A; Handy BC; Datta P
    Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.
    Hirata K; Saruwatari J; Enoki Y; Iwata K; Urata Y; Aizawa K; Ueda K; Shirouzono T; Imamura M; Moriuchi H; Ishima Y; Kadowaki D; Watanabe H; Hirata S; Maruyama T; Fukunaga E
    Ther Drug Monit; 2014 Oct; 36(5):553-5. PubMed ID: 24632808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosphenytoin farewell?
    Horowitz BZ
    Ann Emerg Med; 2004 Mar; 43(3):398-400. PubMed ID: 14985669
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaprozin and 5-(p-hydroxyphenyl)-5-phenylhydantoin interference in phenytoin immunoassays.
    Datta P
    Clin Chem; 1997 Aug; 43(8 Pt 1):1468-9. PubMed ID: 9267337
    [No Abstract]   [Full Text] [Related]  

  • 14. Fosphenytoin.
    Luer MS
    Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies.
    Nelson MH; Birnbaum AK; Nyhus PJ; Remmel RP
    J Pharm Biomed Anal; 1998 Sep; 17(8):1311-23. PubMed ID: 9800650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.
    Dasgupta A; Schlette E
    J Clin Lab Anal; 2001; 15(5):244-50. PubMed ID: 11574952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
    Brauchli YB; Scholer A; Schwietert M; Krähenbühl S
    Clin Chim Acta; 2008 Mar; 389(1-2):174-6. PubMed ID: 18082631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage.
    Kim DW; Kim TE; Ji M; Chun YI
    Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraprotein interference in immunoassays.
    LeGatt DF; Higgins TN
    Ther Drug Monit; 2015 Jun; 37(3):417. PubMed ID: 25478903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.